Skip to content

A randomized controlled clinical study for endometrial repair with estradiol gel after intrauterine adhesion separation

A randomized controlled clinical study for endometrial repair with estradiol gel after intrauterine adhesion separation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022110
Enrollment
Unknown
Registered
2019-03-25
Start date
2019-04-15
Completion date
Unknown
Last updated
2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine Adhesion

Interventions

Study group:Estradiol gel
Control group:estradiol valerate

Sponsors

West China Second University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ? Aged 18-45 years; ? Patients undergoing IUA isolation; ? According to the American fertility association (AFS) IUA prognostic classification score, the score was 5 to 12; ? No use of iud or sex hormone drugs in the first 6 months of the study; ? Liver and kidney function, blood triglycerides, activated protein C activity and hypersensitive c-reactive protein were normal; ? Prothrombin, prothrombin fragments 1 and 2, vascular hemophilia factor (VWF) and coagulation function were normal; ? No abnormality of clinical significance was found in ecg examination; ? Patients who agreed to participate in the study and signed an informed consent.

Exclusion criteria

Exclusion criteria: ? Previous IUA surgical treatment history; ? Combined with other reproductive system diseases, such as reproductive system tumors, infections and tuberculosis (including tuberculous and tumorous IUA); ? Breast tumors and breast hyperplasia and other breast diseases; ? Have a history of thrombotic disease, family history or high risk factors of thrombosis; ? Pre-operation B ultrasound monitoring ovulation without ovulation; ? Participate in other research projects in the previous 3 months; ? According to the researcher's judgment, not suitable for the subject of this study.

Design outcomes

Primary

MeasureTime frame
endometrial thickness;Menstrual recovery;RI, PI;Incidence of postoperative readhesion;Amount of estradiol and estrone in blood;

Countries

China

Contacts

Public ContactKehui Xu

West China Second University Hospital

Xukehui59@163.com+86 13688387687

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026